The Patent Finder
SP

Sunovion Pharmaceuticals Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

40 patents currently held

21 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2028. from the record

Of the 21 now held by other companies, 6 name Pgi Drug Discovery LLC as their current owner, and 15 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
9
Ending by 2030
Jan 2028
Next term end
24
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Nov 23 to 26, 2026 · next Nov 23
  • 1 fee due Dec 2, 2026
    The maintenance fee for Sublingual Apomorphine (US 9,044,475) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
  • 2 fees due Feb 6 to 13, 2027 · next Feb 6
  • 2 fees due Mar 24 to 26, 2027 · next Mar 24
  • 2 fees due Apr 8 to 22, 2027 · next Apr 8
  • 1 fee due Jul 14, 2027
    The maintenance fee for Metabotrophic Glutamate Receptor 5 Modulators and Methods of Use Thereof (US 10,533,000) comes due Jul 14, 2027. Unpaid by Jan 14, 2028, it lapses early.
  • 4 fees due Aug 2 to 25, 2027 · next Aug 2
  • 4 fees due Sep 3 to 30, 2027 · next Sep 3
  • 1 fee due Nov 3, 2027
    The maintenance fee for Sublingual Apomorphine (US 9,326,981) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 5 terms have ended since Aug 17, 2026

What they patent

The 5 largest of its 24 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 7,902,252Inhibitors of D-Amino Acid Oxidase
In force
 · High confidence
In forceHigh confidence
US 8,877,975Cycloalkylamines as Monoamine Reuptake Inhibitors
Grace period ended
 · Low confidence
Grace period endedLow confidence
US 7,718,822Carbamate Stereoisomer
In force
 · High confidence
In forceHigh confidence
US 9,040,588Acetamide Stereoisomer
In force
 · High confidence
In forceHigh confidence
US 8,889,686Method of Decreasing the Bitterness of a Pharmaceutical Dosage Form Containing Zopiclone
In force
 · High confidence
In forceHigh confidence
US 8,053,603Tetralone-Based Monoamine Reuptake Inhibitors
In force
 · High confidence
In forceHigh confidence
US 9,044,475Sublingual Apomorphine
In force
 · Medium confidence
In forceMedium confidence
US 9,326,981Sublingual Apomorphine
In force
 · High confidence
In forceHigh confidence
US 10,420,763Sublingual Apomorphine
In force
 · Medium confidence
In forceMedium confidence
US 8,957,114Formulations, Salts and Polymorphs of Transnorsertraline and Uses Thereof
In force
 · High confidence
In forceHigh confidence
10 of 40 patents shown.
Pro members see all 40.
Pro members: see all 40 patents
Also on record, not counted in the 40: 21 patents in force now held by others · 108 patents ended · 11 applications pending · 89 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited